Jiangsu Aidea Pharmaceutical Co., Ltd.

Jiangsu Aidea Pharmaceutical Co., Ltd. saw a notable increase in its stock performance on July 1, 2026, achieving an intraday high. While the company has faced challenges over longer periods, its recent gains contrast with the broader market trends, reflecting a moment of recovery for the small-cap firm.

Jiangsu Aidea Pharmaceutical Co., Ltd. saw a notable rise in its stock today, contrasting with the broader market's performance. While the company has shown a positive trend over the past week, its longer-term results are mixed, facing challenges such as low profitability and constrained growth prospects.

Jiangsu Aidea Pharmaceutical Co., Ltd. saw a notable decline in its stock today, marking a significant drop over various time frames. The company has struggled with profitability, reflected in a low Return on Capital Employed and a substantial decline in operating profit over the past five years.